Pharmafile Logo
Pharmafocus logo
Advanced Search
vaccination-1215279_960_720

Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s

November 18, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 18, 2020
Research and Development

The coronavirus news this week focuses on the Pfizer-BioNTech vaccine, with clinical trial participants receiving the vaccine saying it created …

News

AstraZeneca’s Brilinta reduces stroke and death risk in head and neck artery atherosclerosis patients

November 17, 2020
Manufacturing and Production

AstraZeneca’s Brilinta (ticagrelor) reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had …

News
dr_reddys_chairman_satish

Pfizer takes legal action against Indian drugmakers over generic cancer drug

November 17, 2020
Manufacturing and Production

Pfizer has filed a petition in a US court against Indian companies Dr Reddy’s Laboratories and Aurobindo Pharma that alleges …

News
shutterstock_159488225

Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn

November 17, 2020
Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …

News
pfizer_finland_hq_february_13_2009

Pfizer launches pilot delivery programme for its coronavirus vaccine

November 17, 2020
Manufacturing and Production

Pfizer is set to launch its first delivery programme for the COVID-19 vaccine it developed with BioNTech. It will be …

News
moderna_norwood_plant

UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy

November 17, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine

US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …

News
512px-ugur_sahin_01

BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year

November 16, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …

News

J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen

November 16, 2020
Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …

News
flu_vaccination_grippe_5115654021_2

British Labour Party calls for new laws to tackle online anti-vaxx campaigns

November 16, 2020
Sales and Marketing

The British Labour Party has called for the implementation of new legal measures to combat anti-vaccination campaigns on the internet …

News
obsessive_compulsive_disorder_8970250666

Antidepressants could treat coronavirus, new study suggests

November 16, 2020
Sales and Marketing

The antidepressant fluvoxamine could treat COVID-19 patients and stop their symptoms from worsening, according to a new study. 

News
1200px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

UK Prime Minister Boris Johnson self-isolating after meeting an MP who had COVID-19

November 16, 2020
Sales and Marketing

The British Prime Minister Boris Johnson has begun working in self isolation after coming into contact with an MP who …

News
shutterstock_2

Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine

November 13, 2020
Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel

Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …

News
guido_rasi

Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role

November 13, 2020
Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma

Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …

News
flu_vaccination_grippe_5115654021_1

India preparing 100 million doses of AstraZeneca’s COVID-19 vaccine for inoculation programme

November 13, 2020
Medical Communications

India is aiming to have 100 million doses of AstraZeneca’s COVID-19 vaccine ready for an inoculation drive beginning next month. …

News
1199px-india_-_varanasi_pharmacy_-_0830

World Health Organization to set up traditional medicines centre in India

November 13, 2020
Medical Communications

The World Health Organization announced today that it will set up the Global Centre for Traditional Medicine in India.  General …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

November 13, 2020
Medical Communications

The top ten news stories this week focus on COVID-19 vaccines, with clinical trial participants who received the Pfizer/BioNTech coronavirus …

News
1200px-astrazeneca_hq_in_cambridge_uk

AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients

November 12, 2020
Business Services AZ, AstraZeneca, Calquence

AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised with COVID-19.  Calquence (acalabrutinib) is …

News

NICE recommends Sanofi’s Cablivi for ultra-rare acute thrombotic thrombocytopenic purpura

November 12, 2020
Sales and Marketing NHS, NICE, Sanofi, pharma

Sanofi’s Cablivi (caplacizumab) has received recommendation from NICE for routine NHS use in England and Wales for the treatment of …

News
steven_ferdman-getty_images

Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data

November 12, 2020
Sales and Marketing COVID-19, Pfizer, Vaccine, pharma

With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026